
NPPA Committee Asks Intas to Clarify Patent Discrepancy in Clozapine ER Pricing Plea
New Delhi: The Multidisciplinary Committee (MDC) of Experts under the National Pharmaceutical Pricing Authority (NPPA) has asked Intas Pharmaceuticals Pvt. Ltd. to furnish clarifications over alleged inconsistencies in the patent details submitted for …